Covid-19 Drugs

COVID-19 Prophylaxis: AIIMS Study Of Healthcare Workers In India Using Ivermectin As A Prophylaxis Shows Reduced COVID-19 Infection

Source: COVID-19 Prophylaxis Nov 09, 2020 4 years ago

COVID-19 Prophylaxis: A recent study by All India Institutes of Medical Sciences (AIIMS)-Bhubaneswar in the Indian state of Odisha found that two doses of the drug ivermectin served as a prophylaxis that resulted in a 73% reduction in COVID-19 infection. In the study that was also propelled by Thailand Medical News research initiatives, ivermectin prophylaxis was taken by 77 controls and ...

COVID-19 Mortality Risk Was Found To Be Reduced By 22-25 Percent In Individuals Taking Statins According To Spanish Study

Source: COVID-19 Mortality Nov 05, 2020 4 years ago

COVID-19 Mortality risk was found to be reduced by 22% to 25% in individuals taking statins according to a Spanish study. The retrospective observational study involved patients taking statins who were 11 years older and had significantly more comorbidities than patients who were not taking statins. A genetic matching (GM) procedure was performed prior to analysis of the mortality risk. ...

COVID-19 Drugs: Beta-Blocker Propranolol, A Cancer Drug Could Be Used To Treat COVID-19 According To Australian And Italian Study

Source: Nov 04, 2020 4 years ago

COVID-19 Drugs: Researchers from the University of South Australia, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS)-Italy and University of Campania-Italy in a new international study propose that beta-blockers could potentially be used to treat COVID-19. COVID-19 disease which has now rapidly spread around the globe causing severe pneumonia is often linked to Acute Respir...

COVID-19 Drugs: 5-Amino Levulinic Acid And Ethacridine Identified As Potential SARS-CoV-2 Inhibitors In Two Separate Studies

Source: COVID-19 Drugs Nov 02, 2020 4 years ago

COVID-19 Drugs: With the current COVID-19 pandemic fast escalating and no effective drugs to date, researchers around the world are desperately trying to find suitable drug candidates to further explore their efficacy against the SARS-CoV-2 coronavirus. In two separate studies, two possible drug candidates that demonstrated to inhibit the SARS-CoV-2 virus were identified, one being 5-Amino Levulin...

BREAKING! COVID-19-Antibodies: Regeneron’s Clinical Trial For Severe COVID-19 Patients Suspended! Possible Adverse Reactions!

Source: COVID-19-Antibodies Oct 30, 2020 4 years ago

COVID-19-Antibodies: The independent data monitoring committee (IDMC) has recommended that Regeneron ‘s clinical trial of its antibody treatment called REGN-COV2 for severe COVID-19 patients needing oxygen or who are on ventilators be suspended with immediate effect. The decision was made in the last 24 hours and Regeneron was legally obliged to comply immediately. On early Fr...

COVID-19 Drugs: Yale Researchers Exploring Using Merofloxacin As Inhibitor of SARS-CoV-2 RNA Translation (-1 PRF Inhibitor)

Source: COVID-19 Drugs Oct 26, 2020 4 years ago

COVID-19 Drugs: Researchers from Yale University School of Medicine in a new study exploring the inhibitory effects of the drug merofloxacin on frameshifting during SARS-CoV-2 replication have reported positive results in vitro studies. The study findings are an important proof-of-concept that supports the potential for targeting −1 PRF (programmed −1 ribosomal frameshifting) as a...

BREAKING! University Of Maryland Study Shows That Aspirin Use Reduces Risk Of Both Mortality And Mechanical Ventilation In Hospitalized COVID-19 Patients

Source: Aspirin-COVID-19 Oct 24, 2020 4 years ago

Aspirin-COVID-19: A new study led by researchers from University of Maryland School of Medicine (UMSOM) shows that hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin. Importantly, aspirin takers were less likely to be placed...

University Of Virginia Study Warns That Dexamethasone May Not Be Beneficial For COVID-19 Patients Who Are Diabetic Or Have Low Albumin Levels

Source: COVID-19 -Dexamethasone Oct 24, 2020 4 years ago

COVID-19 -Dexamethasone: A new study led by researchers from University of Virginia-U.S. along with scientist from Polish Academy of Sciences-Poland, Poznan University of Technology-Poland, Medical University of Bialystok-Poland and University of South Carolina-U.S. has discovered a about how the human body transports dexamethasone, a drug that can increase the survival chances of patients wi...

America Latest: Trump’s Controlled FDA Approves Remdesivir Despite WHO and Other Studies Showing Ineffectiveness In Treating COVID-19

Source: America Latest Oct 23, 2020 4 years ago

America Latest: America is facing a major health crisis with the Trump Administration in power and the degree of incompetency, greed and corruption in play. Already America has a total of more than 8.4 million confirmed COVID-19 cases with realistic figures expected to be much higher due to under-reporting in Republican controlled states and lack of testing among asymptomatic cases and as of today...

Drugs-COVID-19: Massachusetts General Hospital Study Confirms That Overpriced Tocilizumab (Actemra) Ineffective For Treating COVID-19

Source: Drugs-COVID-19 Oct 22, 2020 4 years ago

Drugs-COVID-19: Fortunately another COVID-19 drug scam is being prevented after the remdesivir saga thanks to honest and credible researchers that cannot be manipulated by money. The US FDA under the Trump administration and Trump’s family and cronies has done even damage with hydrochloroquine and remdesivir issues with many American lives lost and hopefully after Trump loses this elections,...

COVID-19 Drugs: Repurposing Ensifentrine, A Chronic Obstructive Pulmonary Disease (COPD) Medication For Treating COVID-19

Source: COVID-19 Drugs Oct 20, 2020 4 years ago

COVID-19 Drugs: Ensifentrine a drug originally developed by UK based pharmaceutical cum biotech company Verona Pharma to treat chronic obstructive pulmonary disease or COPD could be a new treatment option for hospitalized COVID-19 patients. According to research this dual bronchodilator and anti-inflammatory drug be safe and effective in COVID-19 patients experiencing the debilitating effects of s...

LATEST! WHO’s SOLIDARITY Drug Trial Shows That Remdesivir Is Not The Least Effective In Treating COVID-19!

Source: Remdesivir Oct 16, 2020 4 years ago

Remdesivir: Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients. The study results of the trial are under review for publi...

COVID-19 Intranasal Drugs: Novan’s Vitro Study Involving Berdazimer Sodium Demonstrates Antiviral Effect Against SARS-CoV-2 in Human Airway

Source: COVID-19 Intranasal Drugs Oct 15, 2020 4 years ago

COVID-19 Intranasal Drugs: North Carolina based clinical-stage biotechnology company Novan, Inc. that specializes in various nitric oxide based therapeutics has announced that its vitro studies involving its NITRICIL™ platform technology that uses berdazimer sodium has demonstrated antiviral effects against the SARS-CoV-2 coronavirus tha causes the COVID-19 disease. Berdaz...

University Of St Andrews Study Says ILC Therapeutics’ New Alfacyte Inhaled Interferon Might Be A “Significant" COVID-19 Drug Breakthrough

Source: COVID-19 Therapeutics Oct 13, 2020 4 years ago

COVID-19 Therapeutics: According to new research carried out at the University of St Andrews-Scotland, a new inhalation treatment protocol and drug involving synthetic interferons to prevent the spread of COVID-19 is potentially far more effective than currently existing versions of interferons or inhalation protocols. The Scottish biotech company, ILC Therapeutics based in Newhouse...

LATEST! COVID-19 Drugs: Hong Kong University Study Shows That Cheap Ulcer Drug, Ranitidine Bismuth Citrate (Tritec ) Inhibits SARS-CoV-2 in Hamsters

Source: COVID-19 Drugs Oct 12, 2020 4 years ago

COVID-19 Drugs: A new vivo study involving animal models by researchers from Hong Kong University show that the cheap stomach ulcer drug ranitidine bismuth citrate (Tritec) is able to inhibit the SARS-CoV-2 coronavirus. The study team on Monday announced that the anti-microbial drug used to treat stomach ulcers and bacterial infections has shown promise in combatting the coronavirus...

COVID-19 Help: COVID-19 Pandemic Being Approached Wrongly! Emphasis Should Be On Multi-Drug Treatments and Genomics Not Vaccines And Antibodies

Source: COVID-19 Help Oct 11, 2020 4 years ago

COVID-19 Help: While tens of thousands are getting infected daily and thousands are dying each day, millions elsewhere are worried and are trying to find ways to help themselves and their loved ones and the only thing that stupid health authorities and incompetent corrupted governments around the world are doing are giving false hopes by an anticipated COVID-19 vaccine that many think will solve t...

COVID-19 Scams? ‘Loony Dumb Trump’ Backs Approval For Eli Lilly and Regeneron’s Antibody Treatments Despite Insufficient Clinical Data

Source: COVID-19 Scams Oct 09, 2020 4 years ago

COVID-19 Scams? As anticipated, Eli Lily and Regeneron have applied for emergency approval for their laboratory -produced antibodies against COVID-19 and Donald Trump aka ‘Loony Dump Trump’ has signaled his strong presidential backing based on the fact he was treated with them. (There no proof if he was really infected and the whole thing could have been elaborately staged or is ...

COVID-19 Treatments: Spike Glycoprotein Promotes Hyper-Inflammatory Immune Responses Treatable By 4-Phenylburic Acid, Trametinib Or Ulixertinib

Source: COVID-19 Treatments Oct 06, 2020 4 years ago

COVID-19 Treatments: Australian researchers from The University of Newcastle, Hunter Medical Research Institute-New South Wales, University of Technology Sydney and Chinese scientists from Jilin University-Changchun have in a new study confirmed that the SARS-CoV-2 spike glycoprotein subunit 1 can induce a pro-inflammatory signaling pathway (leading to cytokines deployment and epithelial...

COVID-19 Breakthrough: Canadian Study On Unfolded Protein Response (UPR) Uncovers Thiopurines To Stop Viral Replication In Human Coronaviruses

Source: COVID-19 Breakthrough Oct 06, 2020 4 years ago

COVID-19 Breakthrough: Canadian researchers have made a major breakthrough during a study on UPR or unfolded protein response during coronaviruses viral replication leading them to a discovery of thiopurines to stop the viral replication of human coronaviruses including SARS-CoV-2. This breakthrough with further research could lead to a new and effective broad-spectrum therapeutic antiviral that c...

BREAKING! COVID-19 Drugs: Remdesivir Approved By Trump's Administration Causes Serious Kidney Problems. EU Regulators Starts Safety Review!

Source: COVID-19 Drugs Oct 03, 2020 4 years ago

COVID-19 Drugs: An urgent immediate safety review of the drug Remdesivir has been called by the European Medicines Agency after numerous COVID-19 patients taking the drug have developed serious kidney problems. The EU regulator issued a statement a few hours ago saying that it seemed that remdesivir was causing the "acute kidney injury," and that the issue "warrants further...

Drugs-COVID-19: TNF Inhibitors Being Studied By More Experts To Treat COVID-19. University of Oxford Starting New Trial Involving Anti-TNF Drug Adalimumab

Source: Drugs-COVID-19 Oct 01, 2020 4 years ago

Drugs-COVID-19: Anti-tumour necrosis factor (anti-TNF) drugs or TNF inhibitors are now being explored by numerous researchers to treat COVID-19 after recent studies of patients with COVID-19 have shown that patients already taking anti-TNF drugs for inflammatory bowel disease and inflammatory arthritis are less likely to be admitted to hospital. The same was not observed for patients taking other ...

COVID-19 Intranasal Drugs: Australian And British Researchers Exploring TLR2/6 Agonist INNA-051 As An Intranasal Prophylaxis Against COVID-19

Source: COVID-19 Intranasal Drugs Sep 30, 2020 4 years ago

COVID-19 Intranasal Drugs: Researchers from the National Infection Service-UK, Ena Respiratory, Melbourne-Australia, The University of Melbourne-Australia, University of Newcastle-Australia and Oxford University-UK are exploring the usage of TLR2/6 Agonist INNA-051 as an intranasal prophylaxis against COVID-19. To date their vivo studies involving animal models showed that the TLR2 agonis...

COVID-19 Research: University Of Cincinnati Led Study Identifies Sphingosine, A Natural Body Lipid As A Potential Inhibitor Of SARS-CoV-2 And ACE2 Binding

Source: COVID-19 Research Sep 30, 2020 4 years ago

COVID-19 Research: A study led by researchers from the University of Cincinnati along with scientists from University of Duisburg-Germany, the German Primate Center and Saarland University-Germany have discovered that sphingosine, a naturally occurring lipid in the human body could be used as a potential treatment for COVID-19 as prevents binding of SARS-CoV-2 spike to its cellular receptor ...

University Of Connecticut Study Shows Intranasal Povidone-Iodine Limits COVID-19 Spread And Acts As Prophylaxis For Medical Staff

Source: COVID-19-Povidone-Iodine Sep 27, 2020 4 years ago

COVID-19- Povidone-Iodine: A study led by researchers from the University of Connecticut School of Medicine-Farmington along with experts from The Institute for Antiviral Research at Utah State University, Veloce BioPharma-Florida, ProHealth-Farmington and Ocean Ophthalmology-Florida has demonstrated that an antiseptic nasal spray containing povidone-iodine may help curb transmission of the SARS-C...

BREAKING! Metformin Might Emerge As Another COVID-19 Drug Candidate With University of Minnesota Now Receiving Funding For Further Research

Source: Metformin-COVID-19 Sep 26, 2020 4 years ago

Metformin-COVID-19: A few past research studies the last few months has shown the possibility of using metformin, the common cheap and easily available diabetes drug being used for COVID-19 treatments as it was found to reduce severity and mortality rates in COVID-19 patients. In one study, the researchers found that among more than 600 patients with diabetes and COVID-19, use of metformin ...

COVID-19 Treatments: Studies By University Of California Show That Statin Usage Reduces COVID-19 Severity And Indirectly Affects Virus Cell Entry

Source: COVID-19 Treatments Sep 24, 2020 4 years ago

COVID-19 Treatments: Two new studies by researchers from the University of California-San Diego show that statin usage is linked to a lower risk of developing COVID-19 severity and that removing cholesterol from cell membranes prevents the virus from getting into these cells. Furthermore there is some biologic plausibility for a protective role of statins in COVID-19 through known anti-in...

MUST READ! COVID-19 Treatments: Researchers Now Focusing On Nasal Spray Therapeutics To Target The Coronavirus In The Nose To Prevent COVID-19

Source: COVID-19 Treatments Sep 22, 2020 4 years ago

COVID-19 Treatments: Medical researchers and physicians are now trying interrupt the SARS-CoV-2 coronavirus before it gets into the lungs and the rest of the body and starts ravaging the body, targeting not only the lungs, heart and blood vessels but even the cerebrospinal fluids, the brain, the kidneys, the gastroenterological tract , the male testis to even the immune system itself. The...

COVID-19 Scams: Despite Having No Proven Efficacy, Russia Approves First COVID-19 Prescription Drug Coronavir for Sale in Pharmacies That Is Teratogenic!

Source: COVID-19 Scams-Russia Sep 22, 2020 4 years ago

COVID-19 Scams: It was announced that Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies throughout the country as soon as next week, the company said on Friday. The drug’s approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avi...

COVID-19 Scams: Pharma Giants Collaborate To ‘Milk’ More Monies From Governments, Healthcare Agencies And Patients With New Drug Combo For COVID-19

Source: COVID-19 Scams Sep 21, 2020 4 years ago

COVID-19 Scams: Of all the stupidity and craziness which not many people are questioning (the intelligence levels in America has sunk to its lowest!) is the new American standard for drug approvals set by the US FDA under the Trump administration in which as long you can demonstrate somehow by whatever means that a drug is able to shorten hospitalization stays, Voila! You get approved and you can ...

Drugs-COVID-19: Spanish Researchers Identify 4-Phenylbutiric Acid (4-PBA) As Drug Candidate To Treat Inflammatory Issues In COVID-19

Source: Drugs-COVID-19 Sep 21, 2020 4 years ago

Drugs-COVID-19: Spanish researchers from the Department of Cell Biology at the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have identified 4-Phenylbutiric acid or 4-PBA as a possible drug candidate to treat the various inflammatory and immune issues resulting from the SARS-CoV-2 coronavirus infection that causes COVID-19 disease. The s...

BREAKING! Coronavirus Supplements: University Of Nesbraska-US FDA Vitro Study Shows That Bromelain From Pineapples Inhibits SARS-CoV-2 In Vero E6 Cells

Source: Coronavirus Supplements Sep 18, 2020 4 years ago

Coronavirus Supplements: Researchers from the University of Nebraska Medical Center and Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring have demonstrated in vitro studies that bromelain extracted from pineapples is able to inhibit the SARS-CoV-2 coronavirus in Vero E6 cells via a multitude of ways. The study findings are published on a preprint server and are...

Coronavirus Antivirals: Chinese Researchers Identify The Antibiotic Ceftazidime As A Possible Antiviral Candidate To Inhibit SARS-CoV-2 Infections

Source: Coronavirus Antivirals Sep 17, 2020 4 years ago

Coronavirus Antivirals: Researchers from University of Chinese Academy of Sciences, Shanghai-China have identified the antibiotic Ceftazidime as possible antiviral candidate to inhibit SARS-CoV-2 coronavirus and treat the COVID-19 disease. The research findings were published on a preprint server and have yet to be peer reviewed. https://www.biorxiv.org/content/10.1101/2020.09.14.295956v1 ...

COVID-19 Immunotherapy: CPI-006 -Inhibitor Of CD73 Enzymatic Activity Activates Effective B Cell And Humoral Responses To SARS-CoV-2 In Phase 1 Trial

Source: COVID-19 Immunotherapy Sep 17, 2020 4 years ago

COVID-19 Immunotherapy: Researchers from Corvus Pharmaceuticals Inc-California, Temple University-Philadelphia and Icahn School of Medicine at Mount Sinai-New York in a phase 1 clinical trial have demonstrated that using a Inhibitor Of CD73 Enzymatic Activity called CPI-006, the researchers were able to induce the effective B Cell and Humoral response to SARS-CoV-2 infection in COVID-19 patients e...

COVID-19 Meds: Austrian Vitro Study Finds That Nasal Antihistamine Azelastine Could Be Repurposed To Reduce Viral Transmission Or As A Prophylaxis

Source: COVID-19 Meds Sep 17, 2020 4 years ago

COVID-19 Meds: A new vitro study led by Austrian researchers from the University of Vienna has demonstrated that the nasal antihistamine Azelastine was able to inhibit SARS-CoV-2 infections in assays using reconstituted human nasal tissue and Vero E6 monkey kidney epithelial cells. The study team says that Azalastine is a prospective drug candidate that could be used to reduce viral transmission i...

COVID-19 Drugs: Study Shows Azithromycin For Certain COVID-19 Protocols Increases Risks For Cardiac Events If Used With QT-Prolonging Drugs

Source: COVID-19 Drugs Sep 17, 2020 4 years ago

COVID-19 Drugs: Azithromycin, a commonly-prescribed antibiotic that also is being investigated as a potential treatment for COVID-19 according to a new study by researchers from the University of Illinois Chicago, by itself is not associated with an increase in cardiac events; however, if taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increa...

COVID-19 Drugs: University of Pittsburgh Claims Breakthrough With Ab8 A Tiny Antibody Component That Is Able To Neutralizes The SARS-CoV-2 Virus

Source: COVID-19 Drugs Sep 14, 2020 4 years ago

COVID-19 Drugs: Researchers from the University of Pittsburgh School of Medicine claim to have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 coronavirus. The research findings were published in the journal: Cell https://www.cell.com/cell/pdf/S0092-8674(20)31148-X.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%...

COVID-19 Breakthrough: Cancer Drug Silmitasertib Proves Effective In Treating Severe COVID-19 Pneumonia With Patient Discharged After Five Days Of Treatment

Source: COVID-19 Breakthrough Sep 13, 2020 4 years ago

COVID-19 Breakthrough: Clinical-stage biopharmaceutical company Senhwa Biosciences that is based in Taiwan with offices in San Diego has announced that its investigational drug, Silmitasertib has demonstrated remarkable effectiveness after the first patient with severe COVID-19 demonstrated remarkable recovery after using the drug. Senhwa Biosciences is a company focused on next generation DNA Da...

COVID-19 Treatments: Study Shows Using Dual Antihistamines Such As Cetirizine And Famotidine Helps Pulmonary Symptoms In COVID-19 Patients

Source: COVID-19 Treatments Sep 12, 2020 4 years ago

COVID-19 Treatments: Researchers from Mississippi have in a new study found that utilizing both the antihistamines Cetirizine and Famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19. The study findings were published in the journal: Pulmonary Pharmacology & Therapeutics https://www.sciencedirect.com/science/article/pii/S1094553920301462?...

BREAKING! India’s Randomized Controlled PLACID Trial Shows Convalescent Plasma Does Not Improve Outcome Of Moderate COVID-19 Patients

Source: COVID-19 Convalescent Plasma Sep 10, 2020 4 years ago

COVID-19 Convalescent Plasma: An open-label, parallel-arm, phase II, multicentre, randomized controlled trial (PLACID) in India has shown that the use of convalescent plasma as a therapeutic for moderate COVID-19 patients showed no positive effects and did not improve the outcome of the patients. The study findings are published on a preprint server and are currently being peer reviewed. ...

Drugs And COVID-19: NSAIDs Such As Ibuprofen And Diclofenac Does Not Worsen COVID-19 Disease Or Cause Severity According to Latest Danish Study

Source: Drugs And COVID-19 Sep 09, 2020 4 years ago

Drugs And COVID-19: Danish researchers led by Dr Anton Pottegård of the University of Southern Denmark along with other scientists from Aarhus University Hospital and the Danish Medicines Agency have in a new study found that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and diclofenac, is not associated with any adverse effects in people who have tested p...

Drugs-COVID-19: Memorial Sloan Kettering Cancer Center Suggest Using PI3K/mTOR And Topoisomerase Inhibitors To Reduce ACE2 Expression And COVID-19 Risk

Source: Drugs-COVID-19 Sep 08, 2020 4 years ago

Drugs-COVID-19: Researchers from Memorial Sloan Kettering Cancer Center-New York in a new study suggest that using drugs such as PI3K/mTOR And Topoisomerase inhibitors reduces ACE2 expression and reduces risk and an individual’s susceptibility to the SARS-CoV-2 coronavirus that causes the COVID-19 disease. As ACE2 are the main and first receptors that the SARS-CoV-2 coronavirus uses...

BREAKING! Narsoplimab May Prevent And Treat COVID-19 Severity By Halting Complement Cascade Says Researchers

Source: Narsoplimab And COVID-19 Sep 06, 2020 4 years ago

Narsoplimab And COVID-19: Researchers are now saying that treatments for COVID-19 may be focusing on at the wrong elements of the disease based on emerging data from Bergamo, Italy, the epicenter of the pandemic in Europe. Italian researchers realized, as they combed through the data, that COVID-19 is an endothelia injury rather than a pulmonary event and that stopping the complement casc...

COVID-19 ‘Bradykinin Storm’ Hypothesis Gaining Stronghold Among Medical Community And Offers New Avenues For Treatments Using Already-Approved Drugs

Source: COVID-19 Bradykinin Storms Sep 03, 2020 4 years ago

By detailed analysis of data on more than 40,000 genes , 17,000 genetic and 2.5 billion genetic combinations samples linked to COVID-19, researchers from Oak Ridge National Lab in Tennessee have managed by using the world’s second fastest computer called the Summit supercomputer have come up with a hypothesis as to how the SARS-CoV-2 coronavirus affects the human host dubbed the &...

BREAKING! COVID-19 Drugs: Canadian Study Shows That Feline Coronavirus Drug GC376 Has Efficacy Against SARS-CoV-2 And Could Work For Humans

Source: COVID-19 Drugs Aug 28, 2020 4 years ago

COVID-19 Drugs: Canadian researchers from the University of Alberta are preparing to launch clinical trials of a drug called GC376 ( A prodrug of the parent drug called GC373) used to cure a deadly disease caused by a coronavirus in cats and they expect will also be effective as a treatment for humans against COVID-19 after successful vitro studies. The study findings or the vitro trials ...

Nitric Oxide For COVID-19: Study Shows Inhaled Nitric Oxide Could Be Used As An Adjunct Therapy For Pregnant COVID-19 Patients

Source: Nitric Oxide For COVID-19 Aug 27, 2020 4 years ago

Nitric Oxide For COVID-19: According to researchers from Massachusetts General Hospital (MGH), inhaled nitric oxide (NO) can be a valuable adjunct respiratory therapy for pregnant women with severe and critical COVID-19. It was found that the delivery of the therapeutic gas to six COVID-19 pregnant patients admitted to MGH, resulted in a rapid and sustained improvement in cardiopulmonary function...

COVID-19 Diagnostics: Researchers Identify Six Novel Biomarkers To Predict Progression Of Disease Severity In COVID-19 Patients

Source: COVID-19 Diagnostics Aug 27, 2020 4 years ago

COVID-19 Diagnostics: Researchers from Lawson Health Research Institute and Western University in a news study have identified six molecules that can be used as biomarkers to predict how severely ill a patient will become. The research findings were published in the Journal: Critical Care Explorations, the official journal of the Society Of Critical Care Medicine https://journals.lww.com/...

Medical News: Estradiol, The Estrogen Steroid Hormone Might Confer A Certain Degree Of Protection To Women Against COVID-19

Source: Medical News Aug 26, 2020 4 years ago

Medical News: Estradiol, the estrogen steroid hormone might confer a certain degree of protection to females claims a new study by European and American reseachers. According to a new study by researcher from Universitätsmedizin Berlin-Germany, Sapienza University of Rome-Italy, Sant’Andrea University Hospital-Italy and University of Virginia-USA, it appears that wome...

Coronavirus Treatments: Japanese Study Indicates Ciclesonide, An Inhaled Steroid Has Potential For COVID-19 Treatment After Positive Vitro Study

Source: Coronavirus Treatments Aug 26, 2020 4 years ago

Coronavirus Treatments: Japanese researchers from Japan’s National Institute of Infectious Diseases are banking their hopes on an inhaled steroid called ciclesonide as the drug has both antiviral and also anti-inflammatory properties against the SARS-CoV-2 coronavirus. In a recent study, the study team reports the in vitro suppression of both the MERS coronavirus and also the SARS-Cov-2 cor...

BREAKING! COVID-19 Treatments: Second Observational Study Shows Famotidine Associated With Better Outcomes For Hospitalized COVID-19 Patients

Source: COVID-19 Treatments Aug 26, 2020 4 years ago

COVID-19 Treatments: A second clinical observation study, this time conducted by researchers from Harford hospital-Connecticut have demonstrated that administering famotidine to hospitalized COVID-19 patients was associated with a reduction in death and a composite endpoint of either death or intubation. The study involved 878 hospitalized COVID-19 patients of which 83 (9.5%) r...

COVID-19 News: Study Shows That High Blood Pressure Medications Reduces Severity Of COVID-19 Infection And Mortality Risk

Source: COVID-19 News Aug 25, 2020 4 years ago

COVID-19 News: According to new research from the University of East Anglia-UK, medication for high blood pressure could improve COVID-19 survival rates and reduce the severity of infection. The study team meta-analyzed data from a variety of sources involving more than 28,000 patients taking antihypertensives, a class of drugs that are used to treat hypertension also known as high blood ...

COVID-19 News: HP163 Identified As Inhibitor Of Host Factor Aryl Hydrocarbon Receptor (AhR) That Aids Viral Replication In Zika And Possibly COVID-19

Source: COVID-19 News Aug 24, 2020 4 years ago

COVID-19 News: Netherlands based Hercules Pharmaceuticals, a biopharmaceutical company focusing on developing small molecule inhibitors of the Aryl Hydrocarbon Receptor (AhR) for treatment of cancer and viral infections, has announced the publication of promising preclinical in-vivo trial results, showing efficacy of its Aryl Hydrocarbon Receptor (AhR) inhibitor HP163 against Zika virus infection ...

BREAKING! COVID-19 Drugs: Study Trial Of Inhaled Corticosteroids Formoterol/Budesonide Shows Potential As Prophylactic And Treatment Drugs

Source: COVID-19 Drugs Aug 24, 2020 4 years ago

COVID-19 Drugs: A randomized control trial of inhaled corticosteroids (ICS) on COPD patients led researchers to discover that inhaled corticosteroids could downregulate the expression of ACE2 receptors in the bronchial epithelial cells and also the epithelial cells in the airways. Furthermore the inhaled corticosteroids were found to also inhibit a human host protease gene ADAM17 that plays ...

MUST READ! COVID-19 Drugs: Study Shows That Remdesivir Not Effective To Treat Moderate COVID-19 Patients

Source: COVID-19 Drugs Aug 23, 2020 4 years ago

COVID-19 Drugs: Remdesivir has so far emerged as another controversial drug that was approved by the US FDA under the Trump administration for emergency use despite the fact that it not clearly demonstrated its efficacy against the SARS-CoV-2 coronavirus nor was there any long term safety studies ever conducted on it use. It was granted approval merely on the basis that it shortened hospitalizatio...

COVID-19 Drugs: Canadian Study Indicates That Asthma Drugs Zileuton And Montelukast Could Be Repurposed To Prevent COVID-19’s Cytokine Storm

Source: COVID-19 Drugs Aug 20, 2020 4 years ago

COVID-19 Drugs: Canadian researchers from Queen’s University-Ontario Novateur Ventures Inc.-Vancouver in a new study propose that two generic anti-inflammatory drugs, zileuton and montelukast typically used in asthma treatments, be used to treat COVID-19 patients because of their potential to dampen disease progression and severity. The research findings were publi...

COVID-19 Drugs: Study Shows That Hypoxia In COVID-19 Patients May Be Treatable With Lanadelumab, A Kinin B2 Receptor Antagonist Drug

Source: COVID-19 Drugs Aug 20, 2020 4 years ago

COVID-19 Drugs: Researchers from COVID-19 Radboud University Medical Center-Netherlands, University Medical Center Utrecht-Netherlands and University of Bonn-Germany in a new study have shown that patients with hypoxia responded positively to treatment with the drug lanadelumab, a Kinin B2 receptor antagonist. These study findings have led to a follow-up study at ten Dutch hospi...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 2 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 2 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 3 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 3 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 3 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 3 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 5 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 5 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 5 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 6 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 6 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 6 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!

Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Sep 28, 2022 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!

Source: SARS-CoV-2-Cancer
Nov 18, 2021 3 years ago

BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!

Source: COVID-19 Genetics
Nov 13, 2020 4 years ago

Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer

Source: Ozone Water-COVID-19
Nov 05, 2020 4 years ago

BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

Source: BREAKING NEWS
Sep 30, 2020 4 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 5 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 5 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 5 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 5 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 5 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 5 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 5 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 5 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 5 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 5 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

FROM HEALTH INSURANCE

LATEST ON SEPSIS

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM HEALTH INSURANCE

LATEST ON SEPSIS